Exercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumonia

Respirology

Volumn 21, Issue 6, 2016, Pages 1005-1014

  Troy, Lauren K ^a,b   Young, Iven H ^a,b   Lau, Edmund M T ^a,b   Corte, Tamera J ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

exercise; exercise test; idiopathic interstitial pneumonia; interstitial lung disease; oxygen

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY FUNCTION; ENDURANCE TRAINING; EXERCISE; EXERCISE INTENSITY; FORCED VITAL CAPACITY; GAS EXCHANGE; HEMODYNAMICS; HUMAN; INTERSTITIAL PNEUMONIA; LUNG VASOCONSTRICTION; MUSCLE FUNCTION; OXYGEN DESATURATION; OXYGEN SATURATION; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY REHABILITATION; QUALITY OF LIFE; WALKING;

EID: 84978881157     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12650     Document Type: Article

References (92)

1. American Thoracic Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus. Am. J. Respir. Crit. Care Med. 2002; 165: 277–304.
2. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013; 188: 733–748.
3. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788–824.
4. Vogiatzis I, Zakynthinos S. Factors limiting exercise tolerance in chronic lung diseases. Compr. Physiol. 2012; 2: 1779–1817.
5. Harris-Eze AO, Sridhar G, Clemens RE, Gallagher CG, Marciniuk DD. Oxygen improves maximal exercise performance in interstitial lung disease. Am. J. Respir. Crit. Care Med. 1994; 150: 1616–1622.
6. Harris-Eze AO, Sridhar G, Clemens RE, Zintel TA, Gallagher CG, Marciniuk DD. Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease. Am. J. Respir. Crit. Care Med. 1996; 154: 994–1001.
7. Marciniuk DD, Gallagher CG. Clinical exercise testing in interstitial lung disease. Clin. Chest Med. 1994; 15: 287–303.
8. Bye PT, Anderson SD, Woolcock AJ, Young IH, Alison JA. Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen. Am. Rev. Respir. Dis. 1982; 126: 1005–1012.
9. Javaheri S, Sicilian L. Lung function, breathing pattern, and gas exchange in interstitial lung disease. Thorax 1992; 47: 93–97.
10. O'Donnell DE, Chau LK, Webb KA. Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. J. Appl. Physiol. (1985) 1998; 84: 2000–2009.
11. Lourenco RV, Turino GM, Davidson LA, Fishman AP. The regulation of ventilation in diffuse pulmonary fibrosis. Am. J. Med. 1965; 38: 199–216.
12. Kornbluth RS, Turino GM. Respiratory control in diffuse interstitial lung disease and diseases of the pulmonary vasculature. Clin. Chest Med. 1980; 1: 91–102.
13. Burdon JG, Killian KJ, Jones NL. Pattern of breathing during exercise in patients with interstitial lung disease. Thorax 1983; 38: 778–784.
14. Cotes JE. Lung Function: Assessment and Application in Medicine. Blackwell Scientific Publications, Oxford, 1975.
15. Wasserman K, Hansen JE, Sue DY, Stringer WW, Sietsema KE, Sun X, Whipp BJ. Principles of Exercise Testing and Interpretation, Fifth edn. Lippincott Williams and Wilkins, a Wolters Kluwer business, Philadelphia, 2012.
16. Harris-Eze AO, Marciniak SJ. The role of exercise testing in interstitial lung disease. Clin Pulm Med. 1995; 2: 213–220.
17. Agusti AG, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1991; 143: 219–225.
18. Agusti AG, Roca J, Rodriguez-Roisin R, Xaubet A, Agusti-Vidal A. Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis. Eur. Respir. J. 1988; 1: 510–516.
19. Risk C, Epler GR, Gaensler EA. Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease. Chest 1984; 85: 69–74.
20. Wagner PD, Laravuso RB, Uhl RR, West JB. Distributions of ventilation-perfusion ratios in acute respiratory failure. Chest 1974; 65(Suppl.): 32S–35.
21. Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD, Lama V, Kazerooni EA, Gross BH, Toews GB et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am. J. Respir. Crit. Care Med. 2006; 174: 803–809.
22. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP 3rd et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2003; 168: 1084–1090.
23. Miki K, Maekura R, Hiraga T, Okuda Y, Okamoto T, Hirotani A, Ogura T. Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis. Respir. Med. 2003; 97: 482–490.
24. Midgren B, Hansson L, Eriksson L, Airikkala P, Elmqvist D. Oxygen desaturation during sleep and exercise in patients with interstitial lung disease. Thorax 1987; 42: 353–356.
25. Sun XG, Hansen JE, Garatachea N, Storer TW, Wasserman K. Ventilatory efficiency during exercise in healthy subjects. Am. J. Respir. Crit. Care Med. 2002; 166: 1443–1448.
26. Glaser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, Dorr M, Ewert R, Schaper C. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir. Med. 2009; 103: 317–324.
27. Nadel JA, Gold WM, Burgess JH. Early diagnosis of chronic pulmonary vascular obstruction. Value of pulmonary function tests. Am. J. Med. 1968; 44: 16–25.
28. Widimsky J, Riedel M, Stanek V. Central haemodynamics during exercise in patients with restrictive pulmonary disease. Bull. Eur. Physiopathol. Respir. 1977; 13: 369–379.
29. Pouwels-Fry S, Pouwels S, Fournier C, Duchemin A, Tillie-Leblond I, Le Tourneau T, Wallaert B. Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2008; 25: 133–139.
30. Magro CM, Allen J, Pope-Harman A, Waldman WJ, Moh P, Rothrauff S, Ross P Jr. The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis. Am. J. Clin. Pathol. 2003; 119: 556–567.
31. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, Arizono S. Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. Chest 2005; 127: 2028–2033.
32. Mendoza L, Gogali A, Shrikrishna D, Cavada G, Kemp SV, Natanek SA, Jackson AS, Polkey MI, Wells AU, Hopkinson NS. Quadriceps strength and endurance in fibrotic idiopathic interstitial pneumonia. Respirology 2014; 19: 138–143.
33. Marciniuk DD, Sridhar G, Clemens RE, Zintel TA, Gallagher CG. Lung volumes and expiratory flow limitation during exercise in interstitial lung disease. J. Appl. Physiol. (1985) 1994; 77: 963–973.
34. Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest 1996; 109: 1566–1576.
35. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999; 116: 1175–1182.
36. Belkin A, Swigris JJ. Health-related quality of life in idiopathic pulmonary fibrosis: where are we now? Curr. Opin. Pulm. Med. 2013; 19: 474–479.
37. Swigris JJ, Gould MK, Wilson SR. Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest 2005; 127: 284–294.
38. Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR. Depression and functional status are strongly associated with dyspnea in interstitial lung disease. Chest 2011; 139: 609–616.
39. De Vries J, Kessels BL, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur. Respir. J. 2001; 17: 954–961.
40. Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, Maher TM, Renzoni EA, Wells AU, Higginson IJ et al. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax 2012; 67: 804–810.
41. Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE Jr, Martinez FJ, Brown KK. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am. J. Respir. Crit. Care Med. 2012; 185: 1044–1048.
42. American Thoracic S, American College of Chest P. ATS/ACCP statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003; 167: 211–277.
43. Palange P, Ward SA, Carlsen KH, Casaburi R, Gallagher CG, Gosselink R, O'Donnell DE, Puente-Maestu L, Schols AM, Singh S et al. Recommendations on the use of exercise testing in clinical practice. Eur. Respir. J. 2007; 29: 185–209.
44. Blanco I, Villaquiran C, Valera JL, Molina-Molina M, Xaubet A, Rodriguez-Roisin R, Barbera JA, Roca J. [Peak oxygen uptake during the six-minute walk test in diffuse interstitial lung disease and pulmonary hypertension]. Arch. Bronconeumol. 2010; 46: 122–128.
45. Lama VN, Martinez FJ. Resting and exercise physiology in interstitial lung diseases. Clin. Chest Med. 2004; 25: 435–453, v.
46. Wallaert B, Wemeau-Stervinou L, Salleron J, Tillie-Leblond I, Perez T. Do we need exercise tests to detect gas exchange impairment in fibrotic idiopathic interstitial pneumonias? Pulm. Med. 2012; 2012: 657180.
47. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111–117.
48. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, Nakanishi N, Miyatake K. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2000; 161: 487–492.
49. Paciocco G, Martinez FJ, Bossone E, Pielsticker E, Gillespie B, Rubenfire M. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur. Respir. J. 2001; 17: 647–652.
50. Ross RM, Murthy JN, Wollak ID, Jackson AS. The six minute walk test accurately estimates mean peak oxygen uptake. BMC Pulm. Med. 2010; 10: 31.
51. Brown CD, Wise RA. Field tests of exercise in COPD: the six-minute walk test and the shuttle walk test. COPD 2007; 4: 217–223.
52. Hill K, Dolmage TE, Woon L, Coutts D, Goldstein R, Brooks D. Comparing peak and submaximal cardiorespiratory responses during field walking tests with incremental cycle ergometry in COPD. Respirology 2012; 17: 278–284.
53. Bittner V. Six-minute walk test in patients with cardiac dysfunction. Cardiologia 1997; 42: 897–902.
54. Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2005; 171: 1150–1157.
55. du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am. J. Respir. Crit. Care Med. 2011; 183: 1231–1237.
56. Swigris JJ, Olson AL, Shlobin OA, Ahmad S, Brown KK, Nathan SD. Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respirology 2011; 16: 439–445.
57. Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur. Respir. J. 2005; 25: 96–103.
58. Revill SM, Morgan MD, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999; 54: 213–222.
59. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47: 1019–1024.
60. Moloney ED, Clayton N, Mukherjee DK, Gallagher CG, Egan JJ. The shuttle walk exercise test in idiopathic pulmonary fibrosis. Respir. Med. 2003; 97: 682–687.
61. de Boer S, Kolbe J, Wilsher ML. Comparison of the modified shuttle walk test and cardiopulmonary exercise test in sarcoidosis. Respirology 2014; 19: 604–607.
62. Pepin V, Brodeur J, Lacasse Y, Milot J, Leblanc P, Whittom F, Maltais F. Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax 2007; 62: 291–298.
63. Holland AE, Dowman L, Fiore J Jr, Brazzale D, Hill CJ, McDonald CF. Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test. BMC Pulm. Med. 2014; 14: 136.
64. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am. J. Respir. Crit. Care Med. 2003; 167: 735–740.
65. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am. J. Respir. Crit. Care Med. 2001; 164: 1171–1181.
66. van der Plas MN, van Kan C, Blumenthal J, Jansen HM, Wells AU, Bresser P. Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis. Respirology 2014; 19: 268–275.
67. Fell CD, Liu LX, Motika C, Kazerooni EA, Gross BH, Travis WD, Colby TV, Murray S, Toews GB, Martinez FJ et al. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 402–407.
68. Hook JL, Arcasoy SM, Zemmel D, Bartels MN, Kawut SM, Lederer DJ. Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis. Eur. Respir. J. 2012; 39: 359–365.
69. Lederer DJ, Arcasoy SM, Wilt JS, D'Ovidio F, Sonett JR, Kawut SM. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006; 174: 659–664.
70. Swigris JJ, Swick J, Wamboldt FS, Sprunger D, du Bois R, Fischer A, Cosgrove GP, Frankel SK, Fernandez-Perez ER, Kervitsky D et al. Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest 2009; 136: 841–848.
71. Holland AE, Hill CJ, Glaspole I, Goh N, Dowman L, McDonald CF. Impaired chronotropic response to 6-min walk test and reduced survival in interstitial lung disease. Respir. Med. 2013; 107: 1066–1072.
72. Faludi R, Komocsi A, Bozo J, Kumanovics G, Czirjak L, Papp L, Simor T. Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension. Eur. Respir. J. 2008; 31: 475–476.
73. Huez S, Roufosse F, Vachiery JL, Pavelescu A, Derumeaux G, Wautrecht JC, Cogan E, Naeije R. Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? Eur. Respir. J. 2007; 30: 928–936.
74. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys. 2007; 43: 475–485.
75. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD et al. Rehabilitation AETFoP. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013; 188: e13–64.
76. Ferreira A, Garvey C, Connors GL, Hilling L, Rigler J, Farrell S, Cayou C, Shariat C, Collard HR. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009; 135: 442–447.
77. Swigris JJ, Fairclough DL, Morrison M, Make B, Kozora E, Brown KK, Wamboldt FS. Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir. Care 2011; 56: 783–789.
78. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008; 63: 549–554.
79. Kozu R, Jenkins S, Senjyu H. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2011; 16: 1196–1202.
80. Huppmann P, Sczepanski B, Boensch M, Winterkamp S, Schonheit-Kenn U, Neurohr C, Behr J, Kenn K. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur. Respir. J. 2013; 42: 444–453.
81. Holland AE, Hill C. Physical training for interstitial lung disease (review). Cochrane Database Syst. Rev. 2008; (4): CD006322.
82. Bajwah S, Ross JR, Peacock JL, Higginson IJ, Wells AU, Patel AS, Koffman J, Riley J. Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature. Thorax 2013; 68: 867–879.
83. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst. Rev. 2014; (10): CD006322.
84. Holland A, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst. Rev. 2008; (4): CD006322.
85. Holland AE, Hill CJ, Glaspole I, Goh N, McDonald CF. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir. Med. 2012; 106: 429–435.
86. Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2003; 168: 538–542.
87. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, Coke MA, Garrity ER, Sweet SC, Heiney DA et al. Development of the new lung allocation system in the United States. Am. J. Transplant. 2006; 6: 1212–1227.
88. Visca D, Montgomery A, de Lauretis A, Sestini P, Soteriou H, Maher TM, Wells AU, Renzoni EA. Ambulatory oxygen in interstitial lung disease. Eur. Respir. J. 2011; 38: 987–990.
89. Frank RC, Hicks S, Duck AM, Spencer L, Leonard CT, Barnett E. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit? Eur. Respir. J. 2012; 40: 269–270.
90. Crockett AJ, Cranston JM, Antic N. Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst. Rev. 2001; (3): CD002883.
91. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann. Intern. Med. 1980; 93: 391–398.
92. Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681–686.